A validated HPLC method for the monitoring of thiopurine metabolites in whole blood in paediatric patients with inflammatory bowel disease

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 2, 2012, Pages 435-444

  Cangemi, G ^a   Barabino, A ^a   Barco, S ^a   Parodi, A ^a   Arrigo, S ^a   Melioli, G ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Chron's disease; Diagnostic test; Inflammatory bowel disease; Thiopurines

Indexed keywords

6 METHYLTHIOINOSINE; 6 THIOGUANINE NUCLEOTIDE; DRUG METABOLITE; MERCAPTOPURINE; UNCLASSIFIED DRUG; 6 MERCAPTOPURINE DERIVATIVE; 6 METHYLMERCAPTOPURINE; AZATHIOPRINE; THIOGUANINE DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CROHN DISEASE; DRUG DETERMINATION; DRUG METABOLISM; DRUG MONITORING; ERYTHROCYTE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LABORATORY TEST; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RELIABILITY; ULCERATIVE COLITIS; ADOLESCENT; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; INFANT; INFLAMMATORY BOWEL DISEASE; LEUKOCYTE; MEASUREMENT ACCURACY; TREATMENT RESPONSE; VALIDATION STUDY;

EID: 84863699116     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500213     Document Type: Article

References (29)

1. Rubnitz JE, Pui CH. Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemia. Cancer Treat Rev 2003; 29:31-44. (Pubitemid 36395521)
2. Aberra FN, Lichtenstein GR. Review article: monitoring of immunomodulators in inflammatory bowel disease. Aliment Pharmacol Ther 2005; 21:307-19. (Pubitemid 40313935)
3. Van Scoik KG, Johnson CA, Porter WR. The pharmacology and metabolism of the thiopurine drugs 6-mercaptopurine and azathioprine. Drug Metab Rev 1985; 16:157-74. (Pubitemid 16191932)
4. Van Asseldonk DP, de Boer NK, Peters GJ, Veldkamp AI, Mulder CJ, Van Bodegraven AA. Review. On therapeutic drug monitoring of thiopurines in inflammatory bowel disease; pharmacology, pharmacogenomics, drug intolerance and clinical relevance. Curr Drug Metab 2009; 10:981-97.
5. Stocco G, Martelossi S, Barabino A, et al. TPMT genotype and the use of thiopurines in paediatric inflammatory bowel disease. Dig Liver Dis 2005; 37:940-45. (Pubitemid 44382346)
6. Lennard L, Singleton HJ. High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample. J Chromatogr 1992; 583:83-90.
7. Bmscheck T, Meyer H, Wellhrner HH. High-performance liquid chromatographic assay for the measurement of azathioprine in human serum samples. J Chromatogr B 1996; 675:287-94. (Pubitemid 26067259)
8. Rowland K, Lennard L, Lilleyman JS. High-performance liquid chromatographic assay of methylthioguanine nucleotide. J Chromatogr B 1998; 705:29-37. (Pubitemid 28045652)
9. Su Y, Hon YY, Chu Y, Van de Poll ME, Relling MV. Assay of 6-mercaptopurine and its metabolites in patient plasma by high-performance liquid chromatography with diode-array detection. J Chromatogr B 1999; 732:459-68. (Pubitemid 29460862)
10. Haines ML, Ajlouni Y, Irving PM, Sparrow MP, Rose R, Gearry RB, Gibson PR. Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease. Inflamm Bowel Dis 2011; 17:1301-7.
11. Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 2007; 133:423-32. (Pubitemid 47193130)
12. Hyams J, Markowitz J, Otley A, et al. Evaluation of the pediatric Crohn's disease activity index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr 2005; 41:416-21. (Pubitemid 41407602)
13. Dervieux T, Boulieu R. Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC. Clin Chem 1998; 44:551-55. (Pubitemid 28141350)
14. Shipkova M, Armstrong VW, Wieland E, Oellerich M. Differences in Nucleotide Hydrolysis contribute to the differences between erythrocyte 6-thioguanine nucleotide concentrations determined by two widely used methods. Clin Chem 2003; 49:260-68. (Pubitemid 36143448)
15. Dervieux T, Boulieu R. Identification of 6-methylmercaptopurine derivative formed during acid hydrolysis of thiopurine nucleotides in erythrocytes, using liquid chromatography-mass spectrometry, infrared spectroscopy, and nuclear magnetic resonance assay. Clin Chem 1998; 44:2511-15. (Pubitemid 28565664)
16. International Conference on Harmonization (ICH) of Technical Requirements for registration of Pharmaceuticals for Human Use, Topic Q2 (R1): Validation of Analytical Procedures: Text and Methodology, Geneva, 2005.
17. Guidance for industry: Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologies Evaluation and Research (CBER), Rockville, May 2001.
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 327:307-10. (Pubitemid 16134762)
19. Bergan S, Bentdal O, Sødal G, Brun A, Rugstad HE, Stokke O. Patterns of azathioprine metabolites in neutrophils, lymphocytes, reticulocytes, and erythrocytes: relevance to toxicity and monitoring in recipients of renal allografts. Ther Drug Monit 1997; 19:502-9. (Pubitemid 28116825)
20. Keuzenkamp-Jansen CW, van Baal JM, De Abreu RA, de Jong JG, Zuiderent R, Trijbels JM. Detection and identification of 6-methylmercapto-8-hydroxypurine, a major metabolite of 6-mercaptopurine, in plasma during intravenous administration. Clin Chem 1996; 42:380-86. (Pubitemid 26080922)
21. Pike MG, Franklin CL, Mays DC, Lipsky JJ, Lowry PW, Sandborn WJ. Improved methods determining concentration 6-thioguanine nucleotides 6-methylmercaptopurine nucleotides blood. J Chromatogr B 2001; 757:1-9. (Pubitemid 32424452)
22. Erb N, Haverland U, Harms DO, Escherich G, Janka-Schaub G. High-performance liquid chromatographic assay of metabolites of thioguanine and mercaptopurine in capillary blood. J Chromatogr B 2003; 796:87-94. (Pubitemid 38352712)
23. Armstrong L, Sharif JA, Galloway P, McGrogan P, Bishop J, Russell RK. Evaluating the use of metabolite measurement in children receiving treatment with a thiopurine. Aliment Pharmacol Ther 2011; 34:1106-14.
24. Gisbert JP. 6-thioguanine nucleotide (6-TGN) concentrations and efficacy of azathioprine (AZA) and mercaptopurine (MP) in inflammatory bowel disease: the metaza study. J Crohns and Colitis Supplements 2008; 2:7-15.
25. Dubinsky MC, Lamothe S, Yang HY, Targan SR, Sinnett D, Théorêt Y, Seidman EG. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology 2000; 118:705-13. (Pubitemid 30171620)
26. Herrlinger KR, Fellermann K, Fischer C, et al. Thioguanine-nucleotides do not predict efficacy of tioguanine in Crohn's disease. Aliment Pharmacol Ther 2004; 19:1269-76. (Pubitemid 38859503)
27. Lowry PW, Franklin CL, Weaver AL, Pike MG, Mays DC, Tremaine WJ, Lipsky JJ, Sandborn WJ. Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease. Gut 2001; 49:665-70. (Pubitemid 32989203)
28. Belaiche J, Desager JP, Horsmans Y, Louis E. Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease. Scand J Gastroenterol 2001; 36:71-6. (Pubitemid 32147184)
29. Connell WR, Kamm MA, Ritchie JK, Lennard-Jones JE. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut 1993; 34:1081-85. (Pubitemid 23245359)